Dr. Aragao is a Principal at Maple Health Group with strong experience across a variety of quantitative analytical methods, which she has applied to value assessment and HEOR. Dr. Aragao brings a wealth of health economic, market access, and value demonstration experience from both the consulting and pharmaceutical sides of the industry. While she has expert knowledge in strategic data generation planning and execution for Value Demonstration issues, she particularly excels at modelling design to maximize product differentiation and value message / story development for European markets.
Prior to joining Maple Health Group, Dr. Aragao was the European lead for HEOR at Gilead Sciences, where she was responsible for defining the European evidence generation strategy across Gilead Portfolio and ensuring timely and efficient execution with sound KOL engagement. She has 16+ years of experience as a Health Economist in different settings from private to public sector as well as in academia.
Dr. Aragao is a Fulbright scholar holding a Ph.D. from Nova University in Public Health, a MA from Boston University, and a BA with Honours from Nova University in Health Economics.
